Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Key Takeaways
For much of the past decade, AI in dentistry operated in a largely unregulated environment. Tools proliferated, claims multiplied, and practitioners adopted software on the basis of marketing demonstrations and peer recommendations rather than rigorous independent evidence. The regulatory frameworks that governed pharmaceuticals and medical devices were built for a different era — one in which a product’s behaviour could be fully characterised before it left the factory. AI tools learn, adapt, and perform differently across different patient populations. The old frameworks were not built for them.
That period of regulatory ambiguity is ending. If 2024 was the year of AI hype, 2025 was the year of AI accountability. The legal landscape shifted from theoretical debates to concrete enforcement actions and compliance deadlines. Organisations must now move beyond deploying AI to actively governing it.
For dental professionals, this shift carries specific and actionable implications — about which tools carry regulatory clearance, what disclosures patients are now legally entitled to, and what questions practitioners should be asking before they integrate any AI system into their clinical workflow. This article synthesises the current regulatory landscape and introduces the frameworks that are shaping what accountable AI in dental practice will look like.
The Regulatory Landscape: A Patchwork With Teeth
There is no single global AI regulation — and the dental profession operates within a particularly complex multi-jurisdictional environment. But the direction across all major markets is consistent: greater transparency, mandatory accountability, and enforceable consequences for systems that cause harm or discriminate.
The EU AI Act is the most comprehensive framework currently in force. The EU AI Act entered its phased implementation period, with obligations for general-purpose AI models taking effect in August 2025. Providers of foundation models must publish detailed summaries of training data, and downstream users must ensure their systems do not fall into prohibited categories. AI tools used in healthcare — including dental diagnostics and treatment planning software — are classified as high-risk under the Act, subject to the strictest requirements: conformity assessments, technical documentation, post-market monitoring, and human oversight provisions. The EU AI Office will oversee implementation and market surveillance, and organisations should integrate technical documentation, risk logs, and post-market monitoring into product lifecycles to ensure EU market access.
In the United States, the picture is more fragmented but moving rapidly. The US does not have a single comprehensive federal AI law. Instead, regulation comes from a patchwork of state laws, federal agency guidance, and voluntary standards — with four themes running through nearly every AI regulation: transparency, bias prevention, data privacy, and accountability. The FDA’s existing medical device framework applies to AI clinical decision support tools, requiring 510(k) clearance for systems that meet the definition of a medical device — and many dental AI imaging platforms now fall into this category.
At the federal legislative level, the Algorithmic Accountability Act of 2025 has been introduced in both the House and Senate, explicitly covering healthcare including dental and vision applications, and would require covered entities to perform impact assessments of deployed automated decision systems and submit reports to the Federal Trade Commission. The bill has not yet passed, but its introduction signals a clear congressional intent — and its requirements are already influencing voluntary compliance frameworks.
At state level, Colorado passed the first comprehensive state AI law in the United States, requiring deployers of high-risk AI systems to use reasonable care to avoid algorithmic discrimination, mandating impact assessments, transparency disclosures to consumers, and documentation of AI decision-making processes — taking effect in February 2026. For dental practices operating in Colorado, this is no longer a theoretical future requirement. It is current law.
The Patient Disclosure Imperative
One of the most practically urgent developments for dental practices is the emergence of mandatory patient disclosure requirements for AI use in clinical care.
California’s AB 3030 law mandates healthcare providers to disclose to patients every time they use AI tools to facilitate clinical conversations. For a dental practice using AI-powered radiographic analysis — where the system identifies pathology, quantifies bone levels, or flags suspicious lesions before the clinician reviews the image — this raises a direct question: does that constitute AI facilitating a clinical conversation? In many cases, the answer is yes.
Algorithmic transparency helps healthcare leaders strengthen compliance risk management efforts including meeting HIPAA requirements, and many states are enacting new laws to regulate the use of healthcare AI, raising the stakes for regulatory compliance programmes. Practices that have not yet considered their AI disclosure posture need to do so — both for current regulatory compliance and because the direction of travel across all US states is clearly toward greater, not lesser, patient notification requirements.
The broader principle at stake is informed consent. If a patient’s diagnosis, treatment plan, or risk assessment is being shaped by an algorithmic output — even partially, even as a decision support tool — that patient arguably has a right to know. The legal frameworks are catching up with what ethical practice already demands.
The Black Box Problem: Why Transparency Matters Clinically
Beyond regulatory compliance, there is a clinical reason why AI transparency matters — one that goes to the heart of professional responsibility. AI adoption in healthcare is hindered by persistent ethical challenges including algorithmic bias, lack of transparency, privacy risks, and unclear accountability — with existing international frameworks articulating high-level principles but seldom providing operational guidance for clinical deployment.
The black box problem is real and specific. When an AI system recommends a diagnosis or flags a lesion, can the clinician explain why? Can they identify what features in the image drove the output? Can they assess whether the training data on which the model was built adequately represents the patient population sitting in their chair?
When physicians can clearly explain how a healthcare AI system arrived at a clinical decision, they are more able to earn and maintain patient trust. Algorithmic bias poses a risk of misdiagnosis or unequal treatment, as AI systems trained on non-representative datasets may perform poorly for certain patient groups. In dental imaging, this is not hypothetical: AI models trained predominantly on radiographs from one demographic, one imaging system, or one geographic region may perform systematically worse on patients who do not match that profile.
The practical implication is that adopting an AI diagnostic tool without understanding its training data, validation population, and known limitations is not simply a regulatory risk — it is a clinical one.
AI Passports: The Emerging Standard for Accountability
The most promising response to the transparency challenge is the concept of the AI passport — a structured documentation record that travels with an AI model and captures the full provenance of its development, validation, and deployment.
The AI passport framework for health AI covers every stage of the model lifecycle: data collection, algorithm development, validation, regulatory compliance, and retraining and retirement. As data and underlying phenomena evolve over time, AI algorithms may need to be retrained or replaced — involving collecting and preparing new data, re-training the algorithm, and re-validating it for regulatory compliance. The health domain requires specialised instantiation of these stages to account for domain-specific data and workflows.
In practical terms, an AI passport for a dental imaging analysis tool would document: the size, demographic composition, and geographic origin of the training dataset; the imaging systems and acquisition protocols on which the model was validated; the accuracy, sensitivity, and specificity performance metrics with confidence intervals; the date of last retraining and any change in performance metrics; and any known subgroup performance disparities.
This is the information a clinician needs to make an informed professional judgement about whether an AI tool is appropriate for a specific patient population — and it is the information that regulators, starting with the EU AI Act, are beginning to require manufacturers to provide. Practitioners evaluating AI tools should be asking for this documentation as a matter of course. If a manufacturer cannot or will not provide it, that itself is clinically significant information.
The Healthcare AI Trustworthiness Index
Alongside the regulatory frameworks, a practical clinical tool for evaluating AI systems is emerging from the academic literature. A January 2026 paper published in Neurocomputing proposed the Healthcare AI Trustworthiness Index — HAITI — a composite scoring framework designed to operationalise AI trustworthiness in clinical settings.
HAITI synthesises trust dimensions for healthcare AI with measurable metrics for fairness, explainability, privacy, accountability, and robustness — proposing a composite, context-aware readiness score with explicit normalisation, weighting, and uncertainty reporting, alongside a development-deployment-governance blueprint and case studies covering diagnostic bias mitigation and privacy-preserving federated learning.
For dental practitioners evaluating AI tools, the five HAITI dimensions offer a practical due diligence framework. Fairness asks whether the system performs equitably across different patient demographics. Explainability asks whether the reasoning behind outputs can be understood and communicated. Privacy asks how patient data is stored, used, and protected — including whether it is used to retrain the model. Accountability asks who is responsible when the system produces an error. And robustness asks how the system performs under conditions that differ from its training environment.
These are not abstract ethical questions. They are the questions that will determine, in practice, whether an AI tool is safe to use in patient care — and whether, when something goes wrong, the clinician who relied on it will be able to demonstrate that they exercised appropriate professional judgement in adopting it.
Data Privacy: The Dental-Specific Dimension
The data privacy dimension of AI regulation carries specific implications in dentistry that deserve direct attention. Dental AI tools — particularly imaging analysis platforms — handle sensitive patient health data, and often in ways that patients do not fully understand.
Some dental AI tools can reconstruct 3D models of a patient’s face. In the wrong hands, that is not just a privacy issue — it is a security one. Most ethical AI providers anonymise data before using it to improve algorithms, stripping names, IDs, and identifying information. But the question of whether patient data is being used to retrain AI models is one that patients are increasingly asking — and that practices need to be able to answer clearly.
Clinics and platforms are moving toward clearer and more transparent consent processes — informing patients upfront about what data is collected, how it is used, and who has access to it. Audit trails in dental record systems that monitor and log who accessed patient data and when add an extra layer of accountability. Practices that have not reviewed their AI vendors’ data handling agreements in light of current HIPAA obligations and emerging state privacy laws should do so before enforcement closes that window.
What Practices Should Do Now
The regulatory trajectory is clear — and for dental practices that have been passive adopters of AI tools, the time for active governance is now. A practical starting framework involves four steps.
First, audit your current AI tools. Identify every AI system in use in your practice — diagnostic imaging analysis, treatment planning software, patient communication tools, scheduling algorithms. Understand which of these are FDA-cleared medical devices and which are not. Check whether any handle protected health information and whether your vendor agreements address how that data is used.
Second, request transparency documentation. For any AI tool used in clinical decision-making, ask the manufacturer for validation data, training dataset demographics, accuracy metrics, and retraining history. A tool that cannot answer these questions is a tool whose reliability you cannot assess.
Third, review your patient disclosure processes. Determine whether your current consent procedures adequately inform patients that AI tools may contribute to their diagnosis or treatment planning — and update them if not. If you practise in California, this is currently a legal requirement. If you practise elsewhere, it is good professional practice and may become a legal requirement sooner than expected.
Fourth, stay current with regulatory developments. The AI regulatory landscape in healthcare is moving faster than almost any other area of clinical governance. Designating a member of your practice team to monitor relevant regulatory updates — FDA guidance on AI/ML medical devices, state AI legislation, and EFP/ADA position statements on AI ethics — is a proportionate response to a genuinely dynamic environment.
Conclusion
The era of unaccountable AI in dental practice is ending. Regulators across the US, EU, and beyond are building frameworks that place specific obligations on both the developers of AI tools and the clinicians who deploy them. Organisations must now move beyond deploying AI to actively governing it — the legal landscape has shifted from theoretical debates to concrete enforcement and compliance deadlines.
For dental professionals, this is not a burden to be reluctantly managed — it is an opportunity to lead. The profession that builds the strongest culture of AI accountability, transparency, and patient disclosure will be the one best positioned to harness what AI can genuinely offer: faster, more consistent, more accurate clinical assessment in service of better patient outcomes. The tools are extraordinary. The governance must match them.
Sources: Neurocomputing, January 2026 (HAITI framework, Ahadian et al.); CPO Magazine, January 2026 (2026 AI Legal Forecast); Drata AI Regulations Overview, 2026 (state and federal AI laws); Manatt Health AI Policy Tracker, 2025–2026; Congress.gov, H.R.5511 and S.2164, Algorithmic Accountability Act of 2025; EU AI Act enforcement timeline, August 2025; Onspring/Heather Cox, AI Transparency in Healthcare Compliance, August 2025; scanO, Ethical Concerns of AI in Dentistry, June 2025; arXiv:2506.22358v1, AI Model Passport framework, June 2025; Nemko Digital, Global AI Regulations Overview, 2025.
